Versant Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-572
Closed -$5.5K – 2828
2025
Q4
$5.5K Hold
572
– – ﹤0.01% 2223
2025
Q3
$6.97K Hold
572
– – ﹤0.01% 2078
2025
Q2
$4.57K Sell
572
-511
-47% -$3.59K ﹤0.01% 2187
2025
Q1
$7.86K Buy
1,083
+476
+78% +$3.46K ﹤0.01% 1839
2024
Q4
$4.18K Buy
+607
New +$4.17K ﹤0.01% 1839
2024
Q3
– Sell
-847
Closed -$8.93K – 2059
2024
Q2
$8.93K Buy
+847
New +$10.7K ﹤0.01% 1025
2024
Q1
– Sell
-118
Closed -$2.29K – 1930
2023
Q4
$2.29K Sell
118
-1,015
-90% -$18.7K ﹤0.01% 1244
2023
Q3
$24K Buy
1,133
+982
+650% +$25.5K 0.01% 426
2023
Q2
$5.01K Buy
+151
New +$5.56K ﹤0.01% 1040

Other funds holding NUS

Versant Capital Management's NUS Position: Q1 2026 in Review

Versant Capital Management sold out of Nu Skin (NUS) in Q1 2026, closing a stake of 572 shares — an estimated $5.5K sold.

Versant Capital Management first reported a position in NUS in Q2 2023 and held it in 9 quarters. The position peaked at $24K in Q3 2023. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Versant Capital Management reported no remaining Nu Skin position as of Q1 2026 after selling out during the quarter.
  • Versant Capital Management sold 572 Nu Skin shares in Q1 2026, an estimated $5.5K.
  • Versant Capital Management first reported a position in Nu Skin in Q2 2023 and held it in 9 quarters.
  • Versant Capital Management's Nu Skin position peaked at $24K in Q3 2023.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.